It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

Prostate cancer is one of the most common and deadly forms of cancer in men, yet early detection remains a major challenge. That difficulty lies in how subtle the disease can be in its earliest stages ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

A leading professor who specialises in the research of prostate cancer has revealed the one thing all men should know and ask ...

Mical Roy is an Austin-based senior manager in public affairs, a prostate cancer survivor, and a content writer. He's also the co-founder of the Pink and Blue Affair, an annual event in Bastrop County ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...